Published in Drug Law Weekly, January 6th, 2009
Last week, Abbott exercised its option to purchase Ibis. The closing of the acquisition is subject to the satisfaction of other terms and conditions of a stock purchase agreement between the parties and is expected to occur in January 2009.
Keywords: Biosciences, Isis Pharmaceuticals Inc., Pharmaceutical Business,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.